© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
May 01, 2021
The rates of both diseases have been increasingly linked in recent years.
April 30, 2021
The SGLT2 inhibitor is the first of its class to receive indication for treating kidney outcomes regardless of a patient's diabetes status.
A cohort analysis of African American patients finds an association between 1-year ozone concentrations and diagnosed incident diabetes at clinical visit.
New data show a link between body mass index and increased risk of adverse effects from COVID-19.
April 29, 2021
New data show that youths with type 1 diabetes perceive their sleep as disrupted, but investigators find similar objective outcomes in youths without diabetes.
April 28, 2021
Men, individuals with 15 years of type 2 diabetes, and those older than 55 years old had the greatest absolute risk reduction.
April 19, 2021
Anti-VEGF administration did increase the risk of nonocular hemorrhages, mostly in patients with AMD.
April 14, 2021
A new study on dapagliflozin use finds consistent risk reduction in treatment of patients with higher rates of kidney dysfunction.
April 02, 2021
The study represents the first to examine a PPD connection to allopregnanolone.
March 31, 2021
Patients who continued taking semaglutide after an initial 20-week therapy period saw continued weight loss, leading to the hope that a new pharmacologic approach to weight loss could be on the horizon.